ArticleInvestigational new drugs2022

Comparison of dual mTORC1/2 inhibitor AZD8055 and mTORC1 inhibitor rapamycin on the metabolism of breast cancer cells using proton nuclear magnetic resonance spectroscopy metabolomics.

Zhitao Ni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.